Long-term increase in female body condition and its effect on reproduction in two European red-listed species, Common Pochard (Aythya ferina) and Tufted Duck (Aythya fuligula)

Body condition of breeding females is an important driver of an individual’s fitness and the consequent dynamics of populations. Long-term changes in female body condition are likely to be affected by recent shifts in climatic and environmental conditions that can result in changes to population demography. To help explain the drivers shaping body condition during the incubation period and its consequences for reproductive success, we examined the long-term pattern in the body condition of breeding females of two declining sympatric diving duck species: Common Pochard Aythya ferina and Tufted Duck Aythya fuligula. We analysed the data obtained from 139 females of Common Pochard and 251 females of Tufted Duck breeding on fishponds in South Bohemia, Czechia, between 2004 and 2020. We calculated the body condition index of females during late incubation based on the residuals from the relationship between body mass and tarsus length and used the incubation stage as an additional predictor of body mass. Body condition of both species did not decline over the 17 years of the study. The effect of winter weather conditions (winter temperature), water transparency (a proxy for food availability) and reproductive investment on body condition was not confirmed. Female body condition positively affected mean egg mass and hatchability in both studied species, i.e. females in better body condition laid larger eggs and hatched eggs with a higher hatching probability. We conclude that the population declines of the studied species are probably not connected to decreasing body condition of breeding females, but other reasons such as change in breeding propensity or offspring survival and recruitment should be considered in future studies.publishedVersio

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial

Introduction: The purpose was to compare two flexible regimens of intravitreal aflibercept (IVT-AFL) with fixed dosing every 8 weeks, beyond the first year of treatment, in patients with diabetic macular edema (DME). VIOLET was a 100-week, randomized, Phase IIIb, non-inferiority study in patients with center-involving DME previously treated with IVT-AFL for ≥ 1 year according to the European label. Methods: Patients received an initial dose of IVT-AFL at study baseline and were randomly assigned (1:1:1) to treat-and-extend (T&E), pro re nata (PRN), or fixed regimens. The primary endpoint was mean change in best-corrected visual acuity (BCVA) from baseline (randomization) to Week 52. Results: Full analysis set comprised 458 patients (baseline mean BCVA: 72.5, 71.0, and 72.7 letters in the T&E, PRN, and fixed-dose groups, respectively). Patients received a mean (min–max) of 10.0 (2–14; T&E), 11.5 (1–25; PRN), and 12.3 (3–13; fixed) injections over 100 weeks, with 13.3 (4–23), 25.0 (3–29), and 16.1 (5–25) clinic visits, respectively. At Week 52, mean (± standard deviation) BCVA changes from baseline were + 0.5 ± 6.7 (T&E), + 1.7 ± 6.8 (PRN), and + 0.4 ± 6.7 (fixed-dosing) letters (least squares mean difference [95% confidence interval]: T&E 0.01 [− 1.46, 1.47] and PRN 0.95 (− 0.52, 2.42) letters versus fixed dosing; p < 0.0001 for both non-inferiority tests [4-letter margin]). The IVT-AFL safety profile was consistent with previous studies. Conclusion: The treatment burden associated with intravitreal injections for DME is lowest with T&E regimens, but there are a range of flexible IVT-AFL dosing regimens, allowing physicians to adopt an individualized treatment plan. Trial Registration: ClinicalTrials.gov identifier: NCT02818998. © 2022, The Author(s)

Diorganotin(IV) and triorganotin(IV complexes of meso tetra (4 sulfonatophenyl) porphine: do they bind DNA?

It was observed that organometallic porphyrin systems, where the Sn(IV) residue is in side chains, coordinated via sulphonatophenyl groups of porphyrin, show interesting and peculiar in vitro activity, in agreement with the anti-tumour activity of organotin complexes